Sp134

PHENOTYPES-TAILORED DIET ON WEIGHT LOSS

Date
May 6, 2023
Explore related products in the following collection:

Society: AGA

The literature in personalized nutrition in healthcare has been expanding. This program will review the scientific principles of nutritional genomics and metabalomics in predicting and impacting health and disease. The role of circadian rhythm physiology in disease and its role in guiding dietary to impact the gut microbiome-immune axis in health and potentially disease-will also be discussed.

Presenter

Speaker Image for Andres Acosta
Mayo Foundation for Medical Education and Research

Tracks

Related Products

Thumbnail for WEIGHT LOSS OUTCOMES WITH SEMAGLUTIDE BASED ON DIABETES STATUS AND SEVERITY USING THE INDIVIDUALIZED METABOLIC SURGERY SCORE
WEIGHT LOSS OUTCOMES WITH SEMAGLUTIDE BASED ON DIABETES STATUS AND SEVERITY USING THE INDIVIDUALIZED METABOLIC SURGERY SCORE
Background: Transoral outlet reduction endoscopy (TORe) has been shown to be effective in managing weight regain after Roux-en-Y gastric bypass (RYGB), as has the glucagon-like peptide-1 agonist, liraglutide. However, the effect of adjunctive liraglutide after TORe has yet to be assessed…
Thumbnail for GLP-1S IN THE TREATMENT OF OBESITY AND DIABETES
GLP-1S IN THE TREATMENT OF OBESITY AND DIABETES
Enteroendocrine cells play a major role in sensing the luminal contents of the gut and communicating with other organs such as the pancreas, liver and brain. The gut-brain connection is essential in the regulation of food intake…
Thumbnail for MACHINE-LEARNING DRIVEN, FULL PHENOTYPE MODEL AND SURROGATE POLYGENIC RISK SCORE MODEL FOR APPETITE PREDICT RESPONSE TO GLP-1 RECEPTOR AGONIST IN PATIENTS WITH OBESITY
MACHINE-LEARNING DRIVEN, FULL PHENOTYPE MODEL AND SURROGATE POLYGENIC RISK SCORE MODEL FOR APPETITE PREDICT RESPONSE TO GLP-1 RECEPTOR AGONIST IN PATIENTS WITH OBESITY
Background: Transoral outlet reduction endoscopy (TORe) has been shown to be effective in managing weight regain after Roux-en-Y gastric bypass (RYGB), as has the glucagon-like peptide-1 agonist, liraglutide. However, the effect of adjunctive liraglutide after TORe has yet to be assessed…
Thumbnail for REGULATOR OF G-PROTEIN SIGNALING AS AN ENTEROENDOCRINE-SPECIFIC TARGET FOR OBESITY TREATMENT: ALTERED RGS9 IN ENTEROENDOCRINE CELLS IMPAIRS POSTPRANDIAL GLP-1 RESPONSE AND MODIFIES FOOD INTAKE IN MICE
REGULATOR OF G-PROTEIN SIGNALING AS AN ENTEROENDOCRINE-SPECIFIC TARGET FOR OBESITY TREATMENT: ALTERED RGS9 IN ENTEROENDOCRINE CELLS IMPAIRS POSTPRANDIAL GLP-1 RESPONSE AND MODIFIES FOOD INTAKE IN MICE
Enteroendocrine cells play a major role in sensing the luminal contents of the gut and communicating with other organs such as the pancreas, liver and brain. The gut-brain connection is essential in the regulation of food intake…